# Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

> **NCT06279793** · PHASE2 · RECRUITING · sponsor: **GCP-Service International West GmbH** · enrollment: 550 (estimated)

## Conditions studied

- Intensive Care Unit
- Coronary Artery Bypass Grafting (CABG)
- High Risk Patients
- Cardiopulmonary Bypass
- Elective Cardiac Surgery
- Valvular Heart Surgery
- Multiple Valve Surgeries
- Combined Cardiac Procedures
- Aortic Surgical Procedures
- Adult Patients ≥ 18 Years
- Combined Valve and CABG
- Combined Cardiac and Aortic Surgical Procedures

## Interventions

- **DRUG:** Fish Oil
- **DRUG:** Intravenous 0.9% Sodium Chloride

## Key facts

- **NCT ID:** NCT06279793
- **Lead sponsor:** GCP-Service International West GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-15
- **Primary completion:** 2030-03
- **Final completion:** 2030-09
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06279793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06279793, "Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06279793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*